Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

明星药企陨落的悲剧正在发生。 2月21日，基因治疗领域的昔日明星蓝鸟生物（bluebird bio）宣布被私募巨头凯雷集团（Carlyle Group）和SK Capital以总价约1亿美元收购。根据协议，每股股东将获得3美元现金，若公司现有疗法在2027年底前销售额达到6亿美元，还可额外获得6.84美元“奖金”，总价最高近10美元/股。交易需满足多数股东投标、监管批准等条件，预计2025年上半年 ...

The letter is Palliser's third in the last few months as it continues to call for a change in Rio's dual-listed structure, which the investor argues destroys shareholder value and is the root cause of ...

Activist investor Palliser Capital is stepping up a campaign to push Rio Tinto to abandon its primary London listing.

The Saskatchewan Government has announced $6.5 million in funding for the Ronald McDonald House Charities (RMHC). The funding will go towards building Regina's first ever Ronald McDonald House.

The Town of Leader held its regular council meeting on January 7, with Mayor Aaron Wenzel and Councillors Dustin Heatcoat, ...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

AI-driven transformation in telecom is well underway, with network operators pursuing varied AI strategies to improve both ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the ...

CapitaLand Investment Limited (CLI), a real asset manager, closed South Korea private credit fund with a total equity commitment of KRW 180B.